Palamaris, K.; Tzimou, L.-M.; Levidou, G.; Masaoutis, C.; Theochari, I.; Rontogianni, D.; Theocharis, S.
Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors. Int. J. Mol. Sci. 2023, 24, 4263.
https://doi.org/10.3390/ijms24054263
AMA Style
Palamaris K, Tzimou L-M, Levidou G, Masaoutis C, Theochari I, Rontogianni D, Theocharis S.
Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors. International Journal of Molecular Sciences. 2023; 24(5):4263.
https://doi.org/10.3390/ijms24054263
Chicago/Turabian Style
Palamaris, Kostas, Luisa-Maria Tzimou, Georgia Levidou, Christos Masaoutis, Irene Theochari, Dimitra Rontogianni, and Stamatios Theocharis.
2023. "Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors" International Journal of Molecular Sciences 24, no. 5: 4263.
https://doi.org/10.3390/ijms24054263
APA Style
Palamaris, K., Tzimou, L.-M., Levidou, G., Masaoutis, C., Theochari, I., Rontogianni, D., & Theocharis, S.
(2023). Histone Deacetylases (HDACs): Promising Biomarkers and Potential Therapeutic Targets in Thymic Epithelial Tumors. International Journal of Molecular Sciences, 24(5), 4263.
https://doi.org/10.3390/ijms24054263
